EX-10.6 7 dex106.htm MASTER DEVELOPMENT SERVICES AGREEMENT Portions of this exhibit marked [*] have been granted confidential treatment. MASTER DEVELOPMENT SERVICES AGREEMENTMaster Development Services Agreement • May 5th, 2020 • North Carolina
THIS MASTER DEVELOPMENT SERVICES AGREEMENT (the “Agreement”) is made and entered into as of June 14, 2010 (the “Effective Date”) by and between PPD DEVELOPMENT, LP, a Texas limited partnership, with its principal executive offices located at 929 North Front Street, Wilmington, North Carolina 28401 (“PPD”), and FURIEX PHARMACEUTICALS, INC., a Delaware corporation with its principal executive offices located at 3900 Paramount Parkway, Suite 150, Morrisville, North Carolina 27560 (“Sponsor”).
THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED Master Development...Master Development Services Agreement • March 31st, 2020 • Kitov Pharma Ltd. • Pharmaceutical preparations
MASTER DEVELOPMENT SERVICES AGREEMENTMaster Development Services Agreement • October 3rd, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • New York
This Master Development Services Agreement (this “MDSA”) is made and entered into as of the date of last signature below (the “Effective Date”) by and between Kineta, Inc., a Washington corporation having its principal place of business at 219 Terry Avenue North, Suite 300, Seattle, WA 98109 (“Client”), and Samsung Biologics Co., Ltd., a Korean corporation having its principal place of business at 300, Songdo bio-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea (“SBL”). Client and SBL are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EXHIBIT 10.9Master Development Services Agreement • February 2nd, 2001 • Netsol International Inc • Services-prepackaged software • California
